|
|
|
By AR Welch, Editorial & Community Director, Advancing RNA | Once a month, I compile the articles and industry updates I think are most worthy of your time into an unconventional roundup article. Given April 8th's eclipse, I was feeling particularly inspired to make this round-up “eclipse”-themed — and lucky for you, there are tons of songs about eclipses (both celestial and otherwise), some of the lyrics from which also “cross" over into ATMP CMC. |
|
|
|
Speakers in The State Of The mRNA Supply Chain event tackle an audience member’s question around what matters most: What’s in the vial or what’s in the process? |
|
|
|
By Life Science Connect Editorial Staff | As additional mRNA-based cancer immunotherapies vaccines enter clinical development, operational and supply chain challenges must be addressed to reduce turnaround times and COGS. |
|
|
|
By Ash Gude, TBM Consulting | Proactively mitigate supply disruptions with strategic supplier selection and diversification, effective communication, risk management, quality assurance, and more. |
|
|
|
|
| mRNA Product Purification Process Strategies | Article | Cytiva | Impurities from IVT can induce undesired immune responses and negatively impact translation efficiency. Explore the pros and cons of each option for mRNA purification. |
|
|
|
| Study Viral Infection In Resting Human CD4+ T Cells | Application Note | Synthego Corporation | Explore a study proving how synthetic single guide RNAs were used to optimize the editing conditions for resting human CD4+ T cells and maintain high cell viability for several weeks post Nucleofection. |
|
|
|
.png){kind=logo}
